Steve Jones's profile photo

Steve Jones

Sydney

Journalist at Freelance

Contributing Editor at TravelMole

Chief Correspondent at Cannabiz

Freelance journalist, contributor to @cannabiz_au, @mumbrellanews and @medicalrepublic

Featured in: Favicon travelmole.com Favicon cannabiz.com.au Favicon linkedin.com Favicon forbes.com Favicon medium.com Favicon nature.com Favicon thoughtco.com Favicon thenextweb.com Favicon cio.com Favicon thedrum.com

Articles

  • News in brief: InhaleRx R&D tax rebate; ODC to 'share insights'

    1 week ago | cannabiz.com.au | Steve Jones

    InhaleRx has received a research and development tax rebate of $402,000 for FY24, with the company expecting a further $88,000 after lodging an amended tax return for the 2023 financial year. Funds will primarily be used for working capital, with some partially repaying amounts drawn under its $38.5 million funding facility with Clendon Biotech Capital. The Office of Drug Control (ODC) has begun publishing a periodic newsletter to keep companies updated on its activity.

  • Four firms and company director face TGA legal action over alleged unlawful advertising campaign

    1 week ago | cannabiz.com.au | Steve Jones

    The Therapeutic Goods Administration has launched legal action against four firms and a company director over allegations they advertised medicinal cannabis and unlawfully promoted its use for a range of medical conditions.

  • Austranna and Biortica locked in legal tussle over 2023 HLVd outbreak at Green Farmers facility

    1 week ago | cannabiz.com.au | Steve Jones

    Biortica Agrimed and Austranna will renew attempts to settle a legal dispute next month over allegations that Biortica engaged in misleading or deceptive conduct by failing to disclose an outbreak of Hop Latent Viroid (HLVd) at its Green Farmers cultivation facility. In proceedings lodged in the Supreme Court of Victoria, Austranna alleges Biortica knew plants had tested positive for the pathogen in September 2023 but kept Austranna and Queensland grower Medicinal Harvest in the dark.

  • The case for outdoor growing: study suggests sun-grown cannabis may have therapeutic advantages

    1 week ago | cannabiz.com.au | Steve Jones

    Cannabis grown under the sun tends to contain higher levels and a greater range of cannabinoids, has a richer terpene profile and produces far fewer carbon emissions than indoor cultivated plants, researchers have found in a new study exploring the clinical and environmental impacts of outdoor growing.

  • Dr Bonni Goldstein joins Neurotech push to register cannabis drug for paediatric patients

    1 week ago | cannabiz.com.au | Steve Jones

    Renowned US-based cannabis specialist, Dr Bonni Goldstein, has been appointed chief medical advisor at ASX-listed Neurotech International as it continues to develop its broad-spectrum cannabinoid drug for neurological conditions. The company described the appointment as a “major step forward”, with Goldstein adding clinical firepower to its bid to register its medicine, NTI164, in Australia and the US.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
890
Tweets
1K
DMs Open
No
Steve Jones
Steve Jones @stevepjones100
17 Apr 25

@FamiilyAu Hi, I'm a journalist trying to find a contact email address or phone number for the party. Can you help please? Many thanks

Steve Jones
Steve Jones @stevepjones100
18 Oct 23

I'm attending this event. RT if you think others will find this helpful 🙌 https://t.co/iQ47zbGq8J #australiancannabissummit2023

Steve Jones
Steve Jones @stevepjones100
26 Jun 23

ECS Botanics strikes $11.9m dried flower offtake deals https://t.co/hcA8CzSkQI